scispace - formally typeset
H

Hans-Peter Lenhof

Researcher at Saarland University

Publications -  170
Citations -  6982

Hans-Peter Lenhof is an academic researcher from Saarland University. The author has contributed to research in topics: Cancer & Macromolecular docking. The author has an hindex of 44, co-authored 164 publications receiving 6046 citations. Previous affiliations of Hans-Peter Lenhof include Max Planck Society.

Papers
More filters
Journal ArticleDOI

Genome wide expression profiling identifies specific deregulated pathways in meningioma

TL;DR: Extended expression profiling by a novel statistical gene set enrichment identified pathways that have previously not been associated with meningioma that were significantly deregulated biochemical pathways using Kyoto encyclopedia of genes and genomes and Transpath databases.
Journal ArticleDOI

miR-34a as hub of T cell regulation networks

TL;DR: By simultaneous targeting of 14 mRNAs miR-34a acts as major hub of T cell regulatory networks suggesting to utilize miR -34a as target of intervention towards a modulation of the immune responsiveness of T-cells in a broad tumor context.
Journal ArticleDOI

Low miR-150-5p and miR-320b Expression Predicts Reduced Survival of COPD Patients

TL;DR: Molecular profiles measured at the time of a COPD diagnosis have a high predictive power for the survival of patients and the abundance of the oncogenic miR-150-5p in blood of COPD patients was predictive for the development of cancer.
Journal ArticleDOI

Systematic permutation testing in GWAS pathway analyses: identification of genetic networks in dilated cardiomyopathy and ulcerative colitis

TL;DR: This study systematically investigated the impact of three different permutation test approaches for over-representation analysis to detect false positive pathway candidates and evaluated them on genome-wide association data of Dilated Cardiomyopathy and Ulcerative Colitis to provide evidence that the gold standard - permuting the case–control status – effectively improves specificity of GWAS pathway analysis.